8
Participants
Start Date
November 5, 2019
Primary Completion Date
May 20, 2021
Study Completion Date
May 20, 2021
Boiled Peanut Powder
Oral Immunotherapy will be administered utilizing a powder derived from boiled peanuts. Treatment will begin with an initial escalation day in which dosing is begun at 0.1 mg peanut protein and escalated to a final dose of 6 mg peanut protein. Doses are ingested orally. The subjects will continue daily oral ingestion of doses at home and return for updosing every 2 weeks to a final maintenance dose of 300 mg peanut protein. The subjects will continue daily oral ingestion of the peanut product for a minimum duration of 28 days before undergoing exit DBPCFC. At the conclusion of the study, patients will be offered continued maintenance therapy off study in line with current specialty standards.
Cleveland Clinic Foundation, Cleveland
The Cleveland Clinic
OTHER
Alton Melton
OTHER